PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2141
https://www.valueinhealthjournal.com/article/S1098-3015(12)03855-7/fulltext
Title : PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03855-7&doi=10.1016/j.jval.2012.08.2141
First page : A427
Section Title : Cancer
Open access? : No
Section Order : 794
Categories :
Tags :
Regions :
ViH Article Tags :